Genpharmasec Ltd Fixes AGM Date, Approves Director's Report

Genpharmasec Ltd announced the outcome of its Board of Directors meeting held on September 2, 2026. The board has fixed Tuesday, September 29, 2026, as the date for the 34th Annual General Meeting (AGM), to be conducted via Video Conferencing (VC) or Other Audio Visual Means (OAVM). The cut-off date for determining voting rights is set for Tuesday, September 22, 2026, with e-voting commencing on September 26 and concluding on September 28, 2026. Additionally, the board approved the Director's Report and Annual Report for the Financial Year 2025-26, along with the closure of the Share Transfer Book from September 23 to September 29, 2026. The appointment of M/S. Jaymin Modi & Co. as Scrutinizer for the AGM was also approved. Furthermore, the re-appointment of Mr. Sohan Chaturvedi as Whole Time Director, subject to shareholder approval, and approval for advances/loans/guarantees under Section 185 of the Companies Act, 2013, subject to shareholder approval, were considered and approved.